Protein C

DB11312ApprovedInvestigationalProtein Based TherapiesAnticoagulants

Protein C is a medication used to treat protein C deficiency leading to purpura fulminans or coumarin-induced skin necrosis. Protein C is an endogenously occurring plasma protein that plays a key role within the coagulation cascade.

Protein structure of Protein C
Mechanism
Curator reviewed
Primary indication
Protein C concentrate is indicated for pediatric and adult patients with severe congenital protein C deficiency for the prevention and treatment of venous thrombosis and purpura fulminans.Curator reviewed · 4 structured indications
First approval
Canada, 2007 · United States, 2010 · European Union, 2016
Also known as
autoprothrombin IIA · blood coagulation factor XIV · Human protein C · Protein C (coagulation inhibitor) · Protein C concentrate
Brand names
  • Balfaxar
  • Beriplex
  • Ceprotin
  • Kcentra
  • Octaplex

Resolves to

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
638Drug interactionsStructured to mechanism, not free text
Sign in
27Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
26Marketed productsAcross 8 countries and 10 labellers
Sign in
1ATC codeIncluding every combination product, plus 18 drug categories
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Protein C, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account